Duloxetine in Adults With ADHD

  title={Duloxetine in Adults With ADHD},
  author={Mathieu Bilodeau and Tarek Simon and Miriam H. Beauchamp and Paul Lesp{\'e}rance and Simon Dubreucq and Jean-Pierre Dor{\'e}e and Smadar Val{\'e}rie Tourjman},
  journal={Journal of Attention Disorders},
  pages={169 - 175}
Objective: To assess the effect of duloxetine on ADHD in adults. Method: In a 6-week double-blind trial, 30 adults with ADHD received placebo or duloxetine 60 mg daily. The Conners’ Adult ADHD Rating Scale (CAARS) and the Clinical Global Impression Scales (CGI) were used to assess symptom severity and clinical improvement. The Hamilton Anxiety Rating Scale (HARS) and the Hamilton Depression Rating Scale (HDRS) were used to measure the effect on anxiety and depressive symptoms. Results: The… 

Figures and Tables from this paper

ADHD and Anxiety: Clinical Significance and Treatment Implications
Comorbid subjects reported more childhood ADHD symptoms and higher scores on ADHD scales and were more likely to fit criteria for ADHD Emotional Dysregulation Presentation or DSM-IV combined type, and there was no drug-placebo difference in improvement.
Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis
Alternative pharmacological strategies for adult ADHD treatment: a systematic review
Among alternative compounds, amphetamines have the most robust evidence of efficacy, but they may be associated with serious side effects (e.g. psychotic symptoms or hypertension), and antidepressants, particularly those acting as noradrenaline or dopamine enhancers, have evidence of effective but should be avoided in patients with comorbid bipolar disorder.
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)
A review of the scientific literature and of unpublished/ongoing clinical trials to summarize the advances made in the last 10 years for the pharmacological treatment of ADHD found many pharmacological mechanisms beyond dopaminergic and noradrenergic ones have been investigated in patients.
Does serotonin deficit mediate susceptibility to ADHD?
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
Duloxetine may be an effective treatment for mood spectrum disorders, panic disorder, several symptom clusters of borderline personality, and as add-on drug in schizophrenia.
Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders: A Review of Treatment Considerations
Overall, medications are safe, well tolerated, and provide short-term and long-term benefits in patients with ADHD and comorbid SUD.
The Treatment of Adult ADHD: Complexity at Hand
In order to provide specific and targeted interventions, it should be mandatory to address all dimensions (i.e., inattention, impulsivity, hyperactivity, emotional dysregulation) that appeared most affected when the patient asked for help.
Depressive and Anxiety Disorders
Key diagnostic criteria and considerations for differential diagnosis for several common depressive and anxiety disorders are introduced and treatment options are explained.


Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression
Duloxetine demonstrated superior efficacy in the treatment of major depressive disorder, when compared with placebo, regardless of the baseline severity of depressive symptoms, although effect sizes were largest in the most severely depressed patients.
Improvement with Duloxetine in an Adult ADHD Patient
Duloxetine could be an option for patients who either do not tolerate or show resistance to more common pharmacological choices in treating ADHD symptoms.
Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
Venlafaxine may be a promising agent for the treatment of ADHD in adults and controlled clinical trials are needed to further examine this issue.
Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis.
Results of this meta-analysis across all ADHD medications in adult subjects demonstrated statistically significant and clinically robust improvement in symptom severity compared to placebo treatment.
The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults
  • I. Maidment
  • Psychology, Medicine
    Journal of psychopharmacology
  • 2003
The effectiveness data relating to the use of antidepressants in adults with ADHD are reviewed and it is indicated that atomoxetine is less effective than desipramine, and the efficacy of bupropion is unclear.
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature
Duloxetine could be considered an effective treatment option in the treatment of anxiety disorders individually or in comorbidity with each other, or with MDD; however, apart from the well-demonstrated efficacy, tolerability and safety, data on this subject are preliminary and very limited.
Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder.
  • H. Niederhofer
  • Psychology, Medicine
    Primary care companion to the Journal of clinical psychiatry
  • 2010
No study investigating the efficacy of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in treating patients suffering from ADHD was found, and improvement was observed in the ADHD Rating Scale-IV.
Profile of Adverse Events with Duloxetine Treatment
Duloxetine treatment is associated with significantly higher rates of common TEAEs versus placebo, regardless of indication or demographic subgroup, and differences across indications are likely to be attributable to the underlying condition rather than duloxettine.
First preliminary results of a single case report: Duloxetine might improve some symptoms of attention-deficit hyperactivity disorder
Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches
This review focuses on etiology, assessment and treatment of ADHD, in particular alternative treatment approaches with various nonstimulant agents, especially atomoxetine.